StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$1.86−0.03 (-1.84%)

Close on Nov 13, 2026Market cap $84.38MP/E –Yield –

Genelux statistics

63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$84.38M
$275.32M
Enterprise Value
$65.70M
$144.91M
PB Ratio
5.24
2.01
P/TBV Ratio
5.24
2.22

Share statisticsIndustry

Shares Change (YoY)
16.3%
10.8%
Shares Change (QoQ)
0.59%
0.49%
Float
42M
49M
Shares Held by Insiders
7.74%
11.6%
Shares Held by Institutions
21.7%
56.4%

Short sellingIndustry

Short Interest
5M
–
Short Interest Change
-2.44%
-0.80%
Short % of Float
10.9%
8.98%
Short % of Shares Outstanding
10.0%
6.30%
Days to Cover
8.32
5.16

Stock price statisticsIndustry

52-Week High
$6.01
–
52-Week Low
$1.77
–
20-Day Moving Average
$2.03
–
50-Day Moving Average
$2.31
–
200-Day Moving Average
$2.65
–
Average True Range (14)
$0.17
–
Price Change (1 Week)
-4.85%
-1.15%
Price Change (1 Month)
-24.8%
-4.86%
Price Change (3 Months)
-30.9%
-21.1%
Price Change (6 Months)
-36.1%
-20.7%
Price Change (YTD)
-57.2%
-23.6%
Price Change (1 Year)
-68.5%
-22.7%
Price Change (3 Years)
-87.2%
-29.5%
Average Volume (10 Days)
261,483
–
Average Volume (20 Days)
417,787
–
Average Volume (90 Days)
310,080
–
Relative Volume
0.58
0.70
Relative Strength Index (14)
38.8
43.4
Volatility (1 Year)
68.5%
80.1%
Beta (5 Years)
0.61
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-177.9%
-50.3%
Return on Assets (ROA)
-121.8%
-40.6%
Return on Capital Employed (ROCE)
-200.0%
-38.0%

Financial positionIndustry

Current Ratio
2.39
3.30
Quick Ratio
2.34
2.39

GrowthIndustry

Revenue Growth (3Y CAGR)
-91.0%
2.25%

EfficiencyIndustry

WACC
8.14%
10.2%

Income statement (TTM)Industry

Operating Income
-$36.42M
-$21.40M
Net Income
-$35.60M
-$22.39M
EBITDA
-$36.42M
-$17.04M
EPS (Diluted)
-$0.86
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$18.68M
$17.80M
Net Cash Per Share
$0.41
$0.80
Equity (Book Value)
$16.11M
$53.27M
Book Value Per Share
$0.36
$1.50
Tangible Book Value
$16.11M
$26.82M
Working Capital
$11.15M
$79.93M

Cash flow (TTM)Industry

Operating Cash Flow
-$25.28M
-$12.35M
Capital Expenditures
-$3.41M
-$1.00M
Free Cash Flow
-$28.68M
-$18.21M
FCF Per Share
-$0.63
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-42.2%
-22.0%
FCF Yield
-34.0%
-9.44%
Buyback Yield
-22.4%
-0.76%
Shareholder Yield
-22.4%
0.00%

Scores and fair valueIndustry

Altman Z-Score
-15.19
0.23
Piotroski F-Score
1
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodGNLXS&P 500DifferenceGNLX per yearS&P 500 per year
1 month-26.0%-3.0%−23.0 pts
3 months-29.1%-2.8%−26.3 pts
Year to date-57.2%+11.5%−68.7 pts
1 year-66.2%+13.5%−79.6 pts
3 years-86.8%+77.7%−164.5 pts-49.1%+21.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M GNLX shares were sold short on Oct 30, 2026, down 2.4% from the previous report, or 10.85% of the shares available to trade. At recent volumes it would take 8.3 days to buy them back. Over the last 20 sessions, 35.1% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20264,530,210-2.4%544,5948.3
Oct 15, 20264,643,608+6.5%295,50915.7
Sep 30, 20264,362,110+6.5%213,48720.4
Sep 15, 20264,096,285+8.5%284,33114.4
Aug 31, 20263,775,663+7.3%354,59510.7
Aug 14, 20263,517,862+14.1%416,1848.4
Jul 31, 20263,083,334-1.0%152,99920.1
Jul 15, 20263,113,408+3.5%174,00417.9
Jun 30, 20263,007,000-5.6%234,81412.8
Jun 15, 20263,183,715+1.5%152,09420.9
May 29, 20263,136,753+6.0%130,95223.9
May 15, 20262,958,061-6.0%196,17315.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?